Clinical Trial Detail

NCT ID NCT03306264
Title Study of ASTX727 vs IV Decitabine in MDS, CMML, and AML
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Astex Pharmaceuticals, Inc.
Indications

acute myeloid leukemia

myelodysplastic syndrome

chronic myelomonocytic leukemia

Therapies

Decitabine

ASTX727

Age Groups: senior adult

No variant requirements are available.